VALCURIA AB has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in China, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and measurement are KANGMEI BAONING SICHUAN PHARMACEUTICAL CO LTD, Guizhou shenqi pharmaceutical co ltd and GBS GLOBAL BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Hungary | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Drott Kristina | 15 |
#2 | Relander Thomas | 9 |
#3 | Ulvenlund Stefan | 6 |
#4 | Salomonsson Catharina | 6 |
#5 | Drott Johan | 6 |
#6 | Kristina Drott | 1 |
#7 | Johan Drott | 1 |
#8 | Catharina Salomonsson | 1 |
#9 | Stefan Ulvenlund | 1 |
Publication | Filing date | Title |
---|---|---|
US2019099380A1 | Composition and method for pretreating cancer | |
KR20140053871A | A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof |